Guarneri, V., Dieci, M. V., Bisagni, G., Frassoldati, A., Bianchi, G. V., De Salvo, G. L., . . . Conte, P. F. (2019). De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: Results of the PerELISA neoadjuvant study. Ann Oncol.
Chicago ZitierstilGuarneri, V., et al. "De-escalated Therapy for HR+/HER2+ Breast Cancer Patients With Ki67 Response After 2-week Letrozole: Results of the PerELISA Neoadjuvant Study." Ann Oncol 2019.
MLA ZitierstilGuarneri, V., et al. "De-escalated Therapy for HR+/HER2+ Breast Cancer Patients With Ki67 Response After 2-week Letrozole: Results of the PerELISA Neoadjuvant Study." Ann Oncol 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.